News / june 27, 2023
Our first-of-its-kind techno-economic analysis (TEA) for fermentation to help companies project production costs and accelerate path to market.
Today we’re launching Scaler, the first fully interactive, free, online techno-economic analysis (TEA) tool for fermentation that enables companies to project their operating and production costs at commercial scale.
Our goal with Scaler is to promote the growth of biomanufacturing by making it easier for companies to understand what it will require to build and operate at the scale necessary to bring their bioproducts to the mass market.
Companies that are looking for a techno-economic analysis for fermentation can now use Scaler to forecast their costs of production at industrial scale at scaler.bio.
To sign up and start creating your models, visit scaler.bio.
Why we’re developing Scaler
Fermentation holds immense potential across many different applications from food to materials and chemicals. In order to unlock this potential, companies must build long-term plans, including a manufacturing strategy, to accurately forecast their costs of production. But determining commercial-scale manufacturing costs has been a complex and costly challenge that companies in this space have always faced. This is what we think about at Synonym every day.
That’s why we have decided to open up our internal models to the synthetic biology community for free. With Scaler, our goal is to make techno-economic analysis more accessible and enable companies to project their costs of production and operations at commercial scale. With Scaler’s customized output, companies can start setting their commercial roadmaps and manufacturing strategies to understand what it will require to bring their bioproducts to the mass market.
A bit more technical detail on Scaler
At launch, Scaler supports techno-economic modeling for aerobic, aseptic fermentation processes. Over time, our team plans to add more technologies and molecule types to Scaler, making it the most comprehensive, free TEA tool in the market.
Companies that are looking for a techno-economic analysis for fermentation can now use Scaler to model their costs of building a commercial-scale facility and producing at industrial-scale.
Users can refine over 50 parameters in their models, including variables related to fermentation, feedstock, media, downstream processing, financing assumptions and more. After providing these inputs, users receive a customized report with key insights about their process, including:
CapEx & COGS breakdown
Facility sizing matrix
And much more….
How Scaler fits in with Synonym’s overall company vision
Synonym is accelerating the world’s biological future by designing, developing and managing commercial-scale biomanufacturing facilities for startups to Fortune 500 companies. We built Capacitor last year to catalog all existing fermentation capacity and it’s quickly become the most comprehensive directory in the world.
But the obvious conclusion we took away from building Capacitor is that there simply isn’t enough existing capacity. New capacity is expensive, and if we need hundreds of billions of investment to bring new facilities online, we’ll also need to tap into new capital sources. Large-scale biomanufacturing infrastructure will require benchmarks and underwriting that don’t yet exist in synthetic biology. If we’re going to create a new asset class in biomanufacturing infrastructure, we think a framework like Scaler’s is a good place to start.
Scaler is built to help companies of all sizes and ages understand the key metrics and milestones necessary to succeed at the industrial scale and how operational, technical and financial decisions may impact commercial success. This is the data capital providers need to feel comfortable allocating toward a new asset class.
Together, Capacitor and Scaler provide the synthetic biology ecosystem with a powerful, accessible suite of tools to guide companies along their biomanufacturing scale up journey.
We look forward to hearing your feedback about Scaler. If you’d like to get in touch, please reach out to our team at email@example.com.
Synonym enables the commercialization and manufacture of bioproducts—accelerating the world’s transition to better, more sustainable materials and products. It believes that products created using biology will represent the next manufacturing revolution, transforming crucial elements of supply chains across multiple sectors and helping to catalyze a decarbonized future. Synonym works as the strategic biomanufacturing partner for companies building these next-generation bioproducts, helping them to expand and scale seamlessly. It has launched two online tools to help companies on their paths toward commercialization as the first step in their scaling journey: